A case of severe cancer-related pulmonary hypertension; An unexpected resolution.

Cancer Lymphoma Pulmonary hypertension Pulmonary tumor thrombotic microangiopathy Pulmonary veno-occlusive disease Resolution

Journal

Respiratory medicine case reports

ISSN: 2213-0071

Titre abrégé: Respir Med Case Rep

Pays: England

ID NLM: 101604463

Informations de publication

Date de publication:
2022

Historique:

received: 27 04 2022

accepted: 17 05 2022

entrez: 6 6 2022

pubmed: 7 6 2022

medline: 7 6 2022

Statut: epublish

Résumé

Pulmonary hypertension (PH) in cancer patients can be caused by several mechanisms. It can be a direct cancer effect through pulmonary tumor thrombotic microangiopathy, pulmonary tumor emboli, extrinsic compression, intravascular tumors, or a secondary consequence of therapy, including chemotherapy agents, radiation, and stem cell transplantation. We present the first case of complete resolution of cancer-related PH.

Identifiants

DOI: 10.1016/j.rmcr.2022.101671 PMID: 35663111 PMC: PMC9157252

pubmed: 35663111

doi: 10.1016/j.rmcr.2022.101671

pii: S2213-0071(22)00093-4

pmc: PMC9157252

doi:

Types de publication

Case Reports

Langues

eng

Pagination

101671

Informations de copyright

Déclaration de conflit d'intérêts

None of the authors have any conflict of interest.

Références

Pulm Circ. 2019 Apr-Jun;9(2):2045894019851000

pubmed: 31032740

Am J Pathol. 2015 Feb;185(2):356-71

pubmed: 25497573

Eur Respir J. 2019 Jan 24;53(1):

pubmed: 30545968

J Clin Oncol. 2007 Feb 10;25(5):597-9

pubmed: 17290069

Eur Respir Rev. 2019 Feb 6;28(151):

pubmed: 30728162

N Engl J Med. 2021 Dec 16;385(25):2361-2376

pubmed: 34910865

Rev Mal Respir. 2017 Dec;34(10):1045-1057

pubmed: 29153757

Curr Treat Options Cardiovasc Med. 2017 Jun;19(6):44

pubmed: 28466120